Hydrogen/Deuterium Exchange
Skip Navigation Links
Home
About Us
Therapeutic Focus
Technology
News and Publications
Careers
Contact Us
 
H/D Exchange
 
Fee-for-service-contracts
ExSAR has executed hundreds of studies for major pharmaceutical, biopharmaceutical and academic clients. ExSAR offers a collaborative and consultative approach, with verbal and written presentation of results. We strictly adhere to confidentiality obligations, and typical relationships are according to simple fee based terms. We offer feasibility based arrangements as well as usage volume discounting. Scientific leadership includes Dr. Charles Cantor, Dr. William DeGrado, Dr. Arnold Levine and Dr. S. Walter Englander, each members of the National Academy of Science. Projects are conducted under the supervision of Dr. Yoshitomo Hamuro. For additional information or to arrange a web based presentation, please contact Greg Kornhaber at gkornhaber@exsar.com or please contact us here.

H/D Exchange Overview | H/D Exchange Science | H/D Exchange Applications | H/D Exchange Partnering Opportunities
Corporate Partnering Opportunities | Fee-for-service-contracts | Drug Discovery Collaboration


Epitope Mapping
  Hydrogen/Deuterium Exchange Mass Spectrometry (HDMX)
 
Home   |   About Us   |   Therapeutic Focus   |   Technology   |   News and Publications   |   Careers   |   Contact Us   |   Sitemap
ExSAR is a trademark of ExSAR Corporation. Content © 2008 ExSAR Corporation. Terms of Use © 2008
11 Deer Park Drive, Suite 103   |   Monmouth Junction, New Jersey 08852   |   Phone: (732) 438-6500   |   Fax: (732) 438-1919
Optimized for resolutions of 1024 x 768 or higher with Microsoft Internet Explorer 6.0 or later
Web Site Designed and Maintained by Stonehouse Media Incorporated©